Clinical Trials Browser

Phase 1/2 × OTHER × Cholangiocarcinoma × Clear all

NCT03942328 2026-02-24

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT04203160 2025-12-31

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Phase 1/2 Terminated

75 enrolled 17 charts

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT07291947 2025-12-18

PULSAR Combined With Immunotherapy and Chemotherapy

Phase 1/2 Recruiting

Gastrointestinal

Cholangiocarcinoma

NCT07269158 2025-12-08

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT01868490 2025-02-10

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Phase 1/2 Enrolling by invitation

CNSGastrointestinal

Neuroblastoma, Cholangiocarcinoma

NCT04989218 2024-11-05

ICC

Phase 1/2 Terminated

1 enrolled 11 charts

Gastrointestinal

Cholangiocarcinoma

NCT04782804 2022-08-18

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Phase 1/2 Unknown

Gastrointestinal

Cholangiocarcinoma

NCT03943043 2020-07-29

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Phase 1/2 Unknown

Gastrointestinal

Cholangiocarcinoma

NCT02496741 2020-01-09

MACIST

Phase 1/2 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

NCT03633773 2018-08-22

Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma

Phase 1/2 Unknown

GastrointestinalGenitourinary

Medullary cystic kidney disease 1, Cholangiocarcinoma

NCT00955721 2018-01-03

A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer

Phase 1/2 Terminated

9 enrolled 7 charts

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT01692704 2016-03-25

Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy

Phase 1/2 Completed

Gastrointestinal

Cholangiocarcinoma

NCT01073839 2015-09-18

Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.

Phase 1/2 Completed

Gastrointestinal

Cholangiocarcinoma

NCT02528526 2015-08-19

OXY1A

Phase 1/2 Unknown

Gastrointestinal

Hypoxia, Liver Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT01383746 2013-08-07

CHOLANGIOSIR

Phase 1/2 Terminated

Gastrointestinal

Cholestasis, progressive familial intrahepatic 3, Cholangiocarcinoma

NCT00350961 2008-08-26

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

Phase 1/2 Completed

Gastrointestinal

Cholangiocarcinoma